ARTICLE | Clinical News
BAL8557: Phase II data
September 12, 2005 7:00 AM UTC
In a double-blind trial in 160 patients, all 3 doses of BAL8557 met the primary endpoint of non-inferiority to fluconazole on endoscopically confirmed clinical cure. Specifically, confirmed clinical c...